-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, I4jplALywn3XrWL6xy48SfnvcZnYfQLc7m/IdIZtfq7Vocetjk14QILZ1EEUZJzo 4u/jSnTntLEZ9g+e+2dDOg== 0001266375-06-000039.txt : 20060301 0001266375-06-000039.hdr.sgml : 20060301 20060301171740 ACCESSION NUMBER: 0001266375-06-000039 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20060206 FILED AS OF DATE: 20060301 DATE AS OF CHANGE: 20060301 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PROGENICS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000835887 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133379479 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 BUSINESS PHONE: 9147892800 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Olson William C CENTRAL INDEX KEY: 0001327414 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23143 FILM NUMBER: 06656733 BUSINESS ADDRESS: BUSINESS PHONE: (914) 789-2800 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 4 1 edgardoc.xml PRIMARY DOCUMENT X0202 4 2006-02-06 0 0000835887 PROGENICS PHARMACEUTICALS INC PGNX 0001327414 Olson William C 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 0 1 0 0 VP, Research & Development Common Stock 2006-02-06 4 M 0 2000 4 A 20135 D Common Stock 2006-02-06 4 S 0 2000 24.453 D 18135 D Non-Qualified Stock Option (right to buy) 4 2006-02-06 4 M 0 2000 0 D 1999-01-01 2008-01-01 Common Stock 2000 2000 D Sale under a 10b5-1 Plan, which was established in accordance with the policies and procedures of the Issuer, approved by its Board of Directors The Reporting Person is exercising options under this grant in pre-established increments under and in accordance with provisions of a previously established Plan of Sale under Rule 10b5-1, which was established in accordance with the policies and procedures of the Issuer, approved by its Board of Directors. William C. Olson 2006-03-01 -----END PRIVACY-ENHANCED MESSAGE-----